Institut Claudius Regaud-Oncopole

Toulouse, Haute Garonne 31059

0 studies enrolling now · 3 studies all time

What they study most

Advanced Nonhematologic Malignancies, Solid Tumors, UC (Urothelial Cancer)

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201) — Completed
• MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors — Completed
• A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic Malignancies — Completed